image: On June 18 from 1-2pm, the American Federation for Aging Research (AFAR) is hosting a free webinar that we hope will be of interest to you and your constituents. “AI for Longevity Drug Discovery: Breakthroughs and Challenges” will feature founders of biotech companies discussing how AI is aiding the development of therapeutics to extend healthspan and longevity. Moderated by Kristen Fortney, PhD, CEO and Co-Founder, BioAge, the panel will include Mitchell Lee, PhD, CEO and Co-Founder, Ora Biomedical, Inc., Hanadie Yousef, PhD, CEO and Co-Founder, Juvena Therapeutics, Inc., and Alex Zhavoronkov, PhD, CEO and Founder, Insilico Medicine.
Credit: American Federation for Aging Research
WHAT:
Free webinar featuring founders of biotech companies discussing how AI is aiding the development of therapeutics to extend healthspan and longevity.
WHEN:
Tuesday, June 18, 2024, 1-2pm ET
WHERE:
Free on Zoom. RSVP here.
WHO:
Moderator: Kristen Fortney, PhD, CEO and Co-Founder, BioAge,
Panelist: Mitchell Lee, PhD, CEO and Co-Founder, Ora Biomedical, Inc.
Panelist: Hanadie Yousef, PhD, CEO and Co-Founder, Juvena Therapeutics, Inc.
Panelist: Alex Zhavoronkov, PhD, CEO and Founder, Insilico Medicine
Curated by: Sergey Young, AFAR Board Member, and Founder, Longevity Vision Fund
WHY:
AI technologies are transforming biotech landscape by accelerating the discovery of new drug candidates, predicting molecular behaviors, and optimizing clinical trials, and ultimately amplifying the development of promising therapeutics to extend health and delay disease as we grow older. These advancements not only enhance the efficiency of drug development, but also shave off months if not years from the discovery process and save millions of dollars in R&D expenses.
This free webinar is tailored for professionals in the scientific and entrepreneurial communities seeking to gain insights about the real-world applications of AI in drug discovery, as well as the challenges and breakthroughs it presents. Top biotech experts will share their unique experiences from the forefront of longevity research.
CONTACT:
John Chaich, AFAR Director of Communications, john@afar.org
####
The American Federation for Aging Research (AFAR) is a national non-profit organization that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer. For more than four decades, AFAR has served as the field’s talent incubator, providing nearly $200 million to some 4,400 investigators at premier research institutions to date—and growing. In 2023, AFAR provided approximately $12,500,000 to more than 60 investigators. A trusted leader and strategist, AFAR also works with public and private funders to steer high quality grant programs and interdisciplinary research networks. AFAR-funded researchers are finding that modifying basic cellular processes can delay—or even prevent—many chronic diseases, often at the same time. They are discovering that it is never too late—or too early—to improve health. The science funded by AFAR is paving the way for innovative new therapies that promise to improve and extend our quality of life—at any age. Learn more at www.afar.org.